Vaginalaxity. Female genital prolapse
Conditions
Interventions
Intervention group: In this group, treatment was ambulatory and was done in a clinic. Patients are treated with a radiofrequency device in three sessions and each session lasts 30 minutes within 1 to
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
25 Years to 50 Years
Inclusion criteria
Inclusion criteria: Age between 25-50 years Having complaints of vaginal laxity Not having breastfed within the the three months before the study Sexual activity (vaginal sex at least once a month) Normal Pap test result Negative pregnancy test before entering the study
Exclusion criteria
Exclusion criteria: Pelvic organ prolapse has exceeded the hymenal ring (grade 3 and 4 prolapse) Active sexually transmitted disease (Condylomata acuminata / herpes) Chronic vulvar pain or vulvar dystrophy Using known medications that affect sexual function (antihypertensive and psychotropic drugs / chemotherapeutic agents) Daily use of anti-inflammatory drugs which can affect collagen in healing (ibuprofen / aspirin / steroids) Chronic skin disorder including vulvar involvement Medical problem that interferes with wound healing. Thin rectovaginal septum Under treatment for Hypoactive Sexual Desire Disorder (HSDD) or orgasmic disorder Irritable bowel syndrome (IBS)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual function. Timepoint: Before the intervention, at months 1, 2, 3 during the study before each treatment session, and 3and 6 months after the intervention. Method of measurement: Female Sexual Function Index.;Vaginal laxity. Timepoint: Before the intervention, at months 1, 2, 3 during the study before each treatment session, and 3and 6 months after the intervention. Method of measurement: Vaginal Laxity Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzimeh Golzar
Mashhad University of Medical Sciences
Outcome results
None listed